Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

947 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Zhang M, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1033-42. doi: 10.1016/j.ijrobp.2008.06.1489. Epub 2008 Oct 30. Int J Radiat Oncol Biol Phys. 2009. PMID: 18977097 Free PMC article.
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W. Chakravarti A, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):309-17. doi: 10.1016/j.ijrobp.2004.09.047. Int J Radiat Oncol Biol Phys. 2005. PMID: 15890569
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
Chakravarti A, DeSilvio M, Zhang M, Grignon D, Rosenthal S, Asbell SO, Hanks G, Sandler HM, Khor LY, Pollack A, Shipley W; Radiation Therapy Oncology Group. Chakravarti A, et al. Among authors: pollack a. J Clin Oncol. 2007 Jul 20;25(21):3082-9. doi: 10.1200/JCO.2006.08.4152. J Clin Oncol. 2007. PMID: 17634487 Free PMC article. Clinical Trial.
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202.
Che M, DeSilvio M, Pollack A, Grignon DJ, Venkatesan VM, Hanks GE, Sandler HM; RTOG. Che M, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1117-23. doi: 10.1016/j.ijrobp.2007.04.070. Epub 2007 Aug 8. Int J Radiat Oncol Biol Phys. 2007. PMID: 17689883 Free PMC article. Clinical Trial.
Survivin is a potential mediator of prostate cancer metastasis.
Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, Pollack A, Zhang Y, Zietman AL, Shipley WU, Chakravarti A. Zhang M, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1095-103. doi: 10.1016/j.ijrobp.2009.09.007. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231071 Free PMC article.
Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.
Verhoven B, Yan Y, Ritter M, Khor LY, Hammond E, Jones C, Amin M, Bahary JP, Zeitzer K, Pollack A. Verhoven B, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):317-23. doi: 10.1016/j.ijrobp.2013.01.016. Epub 2013 Mar 6. Int J Radiat Oncol Biol Phys. 2013. PMID: 23474109 Free PMC article. Clinical Trial.
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
Khor LY, Desilvio M, Li R, McDonnell TJ, Hammond ME, Sause WT, Pilepich MV, Okunieff P, Sandler HM, Pollack A. Khor LY, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):25-30. doi: 10.1016/j.ijrobp.2006.03.056. Epub 2006 Jul 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16814949 Free PMC article.
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
Roach M 3rd, De Silvio M, Rebbick T, Grignon D, Rotman M, Wolkov H, Fisher B, Hanks G, Shipley WU, Pollack A, Sandler H, Watkins-Bruner D. Roach M 3rd, et al. Among authors: pollack a. Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):79-87. doi: 10.1016/j.ijrobp.2007.03.008. Epub 2007 May 10. Int J Radiat Oncol Biol Phys. 2007. PMID: 17498886 Clinical Trial.
947 results